Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Roccaro

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|October 7, 2023
Rethinking the definition of 'less intensive' for venetoclax-combining regimens in acute myeloid leukaemia patientsE Borlenghi, A M Roccaro, C Cattaneo
Current Cancer Drug Targets|September 22, 2011
Anti-angiogenic therapies in the treatment of Waldenstrom's MacroglobulinemiaA Sacco, I M Ghobrial, A M Roccaro
European Journal of Clinical Investigation|September 27, 2003
Erythropoietin as an angiogenic factorD Ribatti, A Vacca, A M Roccaro, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 17, 2004
Mast cell contribution to angiogenesis related to tumour progressionD Ribatti, E Crivellato, A M Roccaro, et al.
Leukemia|September 23, 2006
The history of the angiogenic switch conceptD Ribatti, B Nico, E Crivellato, et al.
Seminars in Oncology|December 12, 2001
Bone marrow angiogenesis in patients with active multiple myelomaA Vacca, D Ribatti, A M Roccaro, et al.
Journal of Biomedicine & Biotechnology|October 25, 2012
Bone marrow microenvironment in multiple myeloma progressionS Manier, A Sacco, X Leleu, et al.
Acta Haematologica|January 30, 2002
Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myelomaA Vacca, D Ribatti, A M Roccaro, et al.
Leukemia|September 27, 2003
Vascular endothelial growth factor and its receptors in multiple myelomaR Ria, A M Roccaro, F Merchionne, et al.
European Journal of Clinical Investigation|March 16, 2002
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomasR Ria, G Loverro, A Vacca, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|October 7, 2023
Rethinking the definition of 'less intensive' for venetoclax-combining regimens in acute myeloid leukaemia patientsE Borlenghi, A M Roccaro, C Cattaneo
Current Cancer Drug Targets|September 22, 2011
Anti-angiogenic therapies in the treatment of Waldenstrom's MacroglobulinemiaA Sacco, I M Ghobrial, A M Roccaro
European Journal of Clinical Investigation|September 27, 2003
Erythropoietin as an angiogenic factorD Ribatti, A Vacca, A M Roccaro, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 17, 2004
Mast cell contribution to angiogenesis related to tumour progressionD Ribatti, E Crivellato, A M Roccaro, et al.
Leukemia|September 23, 2006
The history of the angiogenic switch conceptD Ribatti, B Nico, E Crivellato, et al.
Seminars in Oncology|December 12, 2001
Bone marrow angiogenesis in patients with active multiple myelomaA Vacca, D Ribatti, A M Roccaro, et al.
Journal of Biomedicine & Biotechnology|October 25, 2012
Bone marrow microenvironment in multiple myeloma progressionS Manier, A Sacco, X Leleu, et al.
Acta Haematologica|January 30, 2002
Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myelomaA Vacca, D Ribatti, A M Roccaro, et al.
Leukemia|September 27, 2003
Vascular endothelial growth factor and its receptors in multiple myelomaR Ria, A M Roccaro, F Merchionne, et al.
European Journal of Clinical Investigation|March 16, 2002
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomasR Ria, G Loverro, A Vacca, et al.
Pageof 2